Komsuoglu Celikyurt I, Mutlu O, Ulak G, Uyar E, Bekta E, Yildiz Akar F, et al
In long COVID and in ME/CFS, alterations of these biomarkers have all been reported (127, 200, 212, 213)
Further anatomical studies are required to confirm whether GLP-1R + SPNs in the C8-T2 IML innervate cardiac postganglionic neurons
For someone already taking a GLP-1 medication, this reinforces the idea that obesity treatment is not cosmetic its a chronic disease treatment and risk-reduction medication. GLP-1s Users Had Lower Rates of Blood Clots, ER Visits, and Death The study analyzed health records from more than 26,000 adults with obesity and at least one autoimmune disease, such as rheumatoid arthritis, psoriatic arthritis, type 1 diabetes, vitiligo, and celiac disease
This baseline matters because it allows you to track whether hormonal improvements occur alongside weight loss, and it helps distinguish between symptoms caused by low testosterone versus other factors like poor sleep, metabolic dysfunction, or nutritional gaps